-
@ Yahoo! Finance - by layer3.news
2025-03-06 05:25:14
nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy
✍️ Novartis' stock has risen sharply after reporting better-than-expected earnings, and its Relative Strength Rating has jumped to 73, indicating strong market leadership.
👉 Novartis' Relative Strength Rating has jumped to 73, indicating strong market leadership.
👉 The company's earnings and revenue growth have accelerated, with earnings up 29% and revenue up 15%.
👉 The stock is forming a long cup base with a buy point of 120.92.
👉 Novartis is developing and marketing branded and generic drugs, as well as consumer health products, vaccines, and diagnostics.
#JamesDeTar #business
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqg9p4r468dm5sk8uvtrxulphau9mqf7hdjrn6v65jp6wla52jdahyqvkmrt6